Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women - Chung, Y E; Lee, S H; Lee, S Y; Kim, S Y; Kim, H H; Mirza, F S; Lee, S K; Lorenzo, J A; Kim, G S; Koh, J M (Osteoporos Int, 2012)